Navigation Links
Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
Date:5/3/2012

ocuments subsequently filed with or furnished to the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and Sequenom, Inc. undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

[Financial tables follow]SEQUENOM, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)Three months endedMarch 31,(unaudited)20122011Revenues:Genetic analysis product sales and services

$
,140$
,844Diagnostic services

4,7801,666Total revenues

14,92013,510Costs and expenses:Cost of genetic analysis product sales and services anddiagnostics services

9,4785,013Gross Margin

5,4428,497Selling and marketing

9,7576,060Research and development

12,66310,722General and administrative

7,3504,838Total operating expenses

29,77021,620Loss from operations

(24,328)(13,123)Other (loss) income, net

(123)404Loss before income taxes

(24,451)(12,719)Income tax (expense) benefit

(2)49Net loss

$
(24,453)$
(12,670)Net loss per share, basic and diluted

$
(0.22)$
(0.13)Weighted average shares outstanding, basic and diluted

110,51298,929
 SEQUENOM, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(in thousands except for par value and share information)March 31,December 31,20122011Assets:

(unaudited)(audited)Cash, cash equivalents, marketable securities

<
'/>"/>
SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call
2. Neuland Labs Reports Financial Results For Fiscal Year 2012
3. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
4. GP Strategies Reports Strong First Quarter 2012 EPS of $0.23
5. Cardinal Health Reports Third-Quarter Results
6. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Neurocrine Biosciences Reports First Quarter 2012 Results
9. CVS Caremark Reports Record First Quarter Results
10. National Study: Teen "Heavy" Marijuana Use Up 80 Percent Since 2008, One in Ten Teens Reports Using Marijuana at Least 20 Times a Month
11. Thoratec Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , LONDON , ... May 20, 2013 Arthroscopy ... Osteoarthritis and Preference for Minimally Invasive Procedures to Drive ... and market trends for the six arthroscopy device market ... arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy visualization ...
(Date:5/20/2013)... 20, 2013  Neuralstem, Inc. (NYSE MKT: CUR) today ... PhD, principal investigator, presented updated Phase I data from ... in the treatment of amyotrophic lateral sclerosis (ALS or ... neuro diabetes special medical symposium in Bucharest, ... "Recent Therapeutic Advances in Stem Cell Therapy," Dr. Feldman ...
(Date:5/20/2013)... With herbal medicines relied upon by consumers ... Pharmacopeial Convention (USP) will provide freely available public standards ... used in these products. Today, USP proposes the first ... Herbal Medicines Compendium ( HMC ) for comment ... . HMC will provide standards for ...
Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3
... LOS ANGELES, Oct. 24, 2011 NeuroSigma, Inc., a ... has signed a contract with the University of California, ... clinical trial to study the use of non-invasive, external ... Deficit Hyperactivity Disorder (ADHD).  NeuroSigma is the exclusive worldwide ...
... HealthWarehouse.com, Inc. (OTC: HEWA), a leading VIPPS-accredited ... begin providing prescription medications for WhiteGlove Health, Inc., ... excited to have a national partner to provide ... Robert Fabbio, co-founder and chief executive officer of ...
Cached Medicine Technology:NeuroSigma Funds First-Ever Pediatric Clinical Trial to Study Non-Invasive External Trigeminal Nerve Stimulation for the Treatment of ADHD 2NeuroSigma Funds First-Ever Pediatric Clinical Trial to Study Non-Invasive External Trigeminal Nerve Stimulation for the Treatment of ADHD 3WhiteGlove Health Selects HealthWarehouse.com to Provide Prescription Medications to its Members Nationwide 2
(Date:5/21/2013)... The National Resident Matching Program NRMP® ... Board of Directors. Hal B. Jenson, M.D., M.B.A, ... Medicine, has been named President. Maria C. Savoia, ... California San Diego, is the President-Designate, and Glenn A. ... Center, is the Secretary-Treasurer. Kenneth B. Simons, M.D., ...
(Date:5/21/2013)... 2013 Joe Vitale, a positive thinking guru ... of the Fisker electric car. After a year and a ... car company went bankrupt, the bestselling author turned grumpy car ... "It's a gas guzzler's anthem," says Vitale, 59, who recorded ... Will Rise." , Owning this Fisker was a personal ...
(Date:5/21/2013)... Limited mobility affects people in ways that ... more difficult to walk around, but everyday tasks like getting ... variety of medical products made to assist those who need ... toilet seat. , Raised toilet seats keep users ... up or sit down. They come in a variety of ...
(Date:5/20/2013)... This week has been dedicated as National ... 19th-May 25th) is an awareness campaign designated to help prevent ... dog owners to properly train their pets, and educate children ... bite lawyers at Buckfire & Buckfire, P.C. represent victims ... The personal injury law firm is a large advocate of ...
(Date:5/20/2013)... 2013 Recent environmental concerns have ... green and sustainable inputs in packaging products. As ... to promote the use of sustainable materials, thereby ... Services industry . “Tax subsidies and operating cost ... industry analyst Deonta Smith. “For example, many packaging ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:Upset Fisker Owner Records Gas Guzzler Anthem 2Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3
... less useful, but some experts disagree , , MONDAY, March ... undermined the value of the prostate-specific antigen (PSA) test ... study asserts. , However, that assertion was immediately challenged ... Cancer Society recommends annual screening for prostate cancer for ...
... Inc. (Nasdaq: MLNM ) today announced that ... Healthcare Conference will be webcast,live and may be ... Company,s,website, http://www.millennium.com ., (Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO ... update on VELCADE(R) (bortezomib) for,Injection and product candidates ...
... Cadient campaigns nominated for Best Non-Branded Web site, Best ... Web site, and Best Digital Media Campaign, WEST ... interactive marketing agency serving the healthcare,industry, announced today it ... Awards. Award winners will be announced at the DTC,National ...
... (http://www.NBTY.com ), a leading global manufacturer and marketer ... the,presentation by Harvey Kamil, President and Chief Financial Officer ... New York on Tuesday,March 11, 2008., The presentation ... Company Web,site, http://www.nbty.com on Tuesday, March 11, ...
... DENVER, March 10 Tea-based ingredients are ... and Colorado-based Sage,Group(R), a self-described ,tea think-tank, ... now outnumber beverage,tea offerings on a global ... and other tea derivatives are being formulated ...
... WILLISTON, Vt., March 10 Laborie Medical Technologies,today ... given clearance to proceed with marketing efforts for ... the US Food and Drug Administration,(USFDA)., Laborie ... its internationally-recognized quality system (ISO-13485) so that,TETRA(TM) can ...
Cached Medicine News:Health News:PSA Test Losing Diagnostic Value, Study Says 2Health News:PSA Test Losing Diagnostic Value, Study Says 3Health News:Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation 2Health News:Cadient Group Receives Multiple Nominations for 2008 DTC National Advertising Awards 2Health News:NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares 2Health News:NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares 3Health News:Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products 2Health News:Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products 3Health News:Laborie Medical Technologies Receives FDA Pre-Market Clearance for TETRA(TM)- NIRS Accessory for the US Market 2
The WaveMap provides immediate clinical decision making information with automatic calculation of pressure gradients and FFR measurements.,SmartWire Pressure Guide Wire - The intelligent choice in ...
... for vascular access. Hollow stylet ... wall puncture with two-part needle. ... visualized while maintaining thumb position ... the hub of the stylet. ...
Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 24 gage needle stick is desired....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Medicine Products: